ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Heme-glycolysis interplay in oral squamous cell carcinoma: insights into SLC48A1 and GLUT1 expression across histological grades.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study investigates the immunohistochemical expression of SLC48A1 and GLUT-1 in different grades of oral squamous cell carcinoma (OSCC) and explores their potential association with the development of tumor. OSCC is a heterogeneous malignancy characterized by increased glycolysis and glucose oxidation. Heme plays a crucial role in oxidative metabolism and ATP production via mitochondrial oxidative phosphorylation. SLC48A1 (solute carrier family 48 member 1) facilitates GLUT-1 trafficking, enhancing glucose uptake and lactate production, thereby promoting cancer cell migration and invasion. However, the relationship between SLC48A1, GLUT-1, and OSCC remains poorly understood. MATERIALS AND
methodsSeventy-two formalin-fixed, paraffin-embedded OSCC tissue samples and ten normal oral mucosa (NOM) were analyzed using immunohistochemistry to assess SLC48A1 and GLUT-1 expression. Staining intensity and distribution were correlated with histopathological grades. Statistical analysis was conducted to evaluate their association with tumor behavior.
resultsGLUT-1 expression showed strong expression in cases of well-differentiated OSCC, supporting its association with tumor. SLC48A1 expression was also seen to be markedly elevated in few cases of poorly differentiated OSCC.
conclusionWhile GLUT-1 expression correlates directly with OSCC, SLC48A1 expression was not seen to be uniformly distributed across the different histological grades. Through this study, it has been proven that both markers hold diagnostic significance and the results of the present study may serve as a future milestone for exploring these markers as potential therapeutic target for disrupting cancer metabolism as well as to correlate with the progression in different grades of OSCC.
Indexed as
Identifiers
41604111What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.